NasdaqGS:BMRNBiotechs
Taking a Fresh Look at BioMarin Pharmaceutical’s (BMRN) Valuation After Its Recent Share Price Rebound
BioMarin Pharmaceutical (BMRN) has quietly shifted gears lately, with the stock gaining about 11% over the past month even as its one year return is still negative and trailing the broader biotech space.
See our latest analysis for BioMarin Pharmaceutical.
That recent 11.3% 1 month share price return at around 59.45 looks more like a cautious reset than a full comeback. This is especially the case with the 1 year total shareholder return still down double digits and longer term TSR deeply...